Characterizing the longitudinal patterns of substance use among individuals diagnosed with serious mental illness after psychiatric hospitalization.
- Authors
- Bahorik, Amber L; Newhill, Christina E; Eack, Shaun M
- Year
- 2013
- Journal
- Addiction (Abingdon, England)
- PMID
- 23432626
- DOI
- 10.1111/add.12153
- PMCID
- PMC3679358
AIM: To characterize longitudinal patterns of substance use across a large sample of psychiatric patients discharged from inpatient admission, followed for 1-year post-hospitalization. DESIGN: Prospective cohort study. SETTING: Kansas City, MO, USA; Pittsburgh, PA, USA; Worcester, MA, USA. PARTICIPANTS: Eight hundred and one schizophrenia-spectrum (n = 204), bipolar (n = 137) and depressive disorder (n = 460) patients from the MacArthur Violence Risk Assessment Study. MEASUREMENTS: Symptoms, functioning, drug/alcohol use assessed by the Brief Psychiatric Rating Scale, the Global Assessment of Functioning, and substance use interviews. FINDINGS: Patients used alcohol (67.0%; n = 540) and cannabis (30.0%; n = 237) more frequently than other substances up to 30 days before admission, and those with depressive and schizophrenia-spectrum used heroin more than individuals with bipolar (P = 0.023). Post-hospitalization, patients using alcohol (B = -0.15, P < 0.001) and cannabis (B = -0.27, P < 0.001) decreased, but patterns varied across diagnosis and genders. Patients using cannabis decreased at greater rates in depressive and schizophrenia-spectrum compared with bipolar (all P < 0.05), and more men used alcohol (B = 0.76, P < 0.001) and cannabis (B = 1.56, P < 0.001) than women. Cannabis (B = 1.65, P < 0.001) and alcohol (B = 1.04, P = 0.002) were associated with higher symptomatology; cannabis (B = -2.33, P < 0.001) and alcohol (B = -1.45, P = 0.012) were associated with lower functioning. CONCLUSIONS: Substance use is frequent and associated with poor recovery in patients with serious mental illness recently discharged from psychiatric hospitalization. Addiction treatments personalized by diagnosis and gender may be effective for improving outcomes in people with serious mental illness.
One-Year Patterns of Alcohol Use Among Men and Women with Schizophrenia-Spectrum, Bipolar, and Depressive Disorders.
One-Year Patterns of Cannabis Use Among Men and Women with Schizophrenia-Spectrum, Bipolar, and Depressive Disorders.
No entities extracted from this document yet.
No uploaded files.
In this knowledge base
| Title | Year | PMID |
|---|---|---|
| A Prospective Comparison of Bipolar I and II Subjects with and without Comorbid Cannabis Use Disorders from the COGA Dataset. | 2023 | 37626487 |
External
| Title | Authors | Journal | Year | Link |
|---|---|---|---|---|
| Managing Co-Occurring Disorders on Adolescent Inpatient Psychiatric Units. | Chang C et al. | — | 2025 | → |
| The Youth Risk Index: psychometrics, predicting the initiation of early adolescent substance use, and the breadth of liability detected. | Ridenour TA et al. | — | 2025 | → |
| Examining the Relationship Between Cannabis Use and Mood, Anxiety, and Psychotic Symptoms in Psychiatric Patients with Severe Concurrent Mental Health and Substance Use Disorders Before and After Recreational Cannabis Legalization in Canada. | Thiessen KA et al. | — | 2024 | → |
| A Prospective Comparison of Bipolar I and II Subjects with and without Comorbid Cannabis Use Disorders from the COGA Dataset. | Preuss UW et al. | — | 2023 | → |
| Canadian Network for Mood and Anxiety Treatments (CANMAT) Task Force Report: A Systematic Review and Recommendations of Cannabis use in Bipolar Disorder and Major Depressive Disorder. | Tourjman SV et al. | — | 2023 | → |
| Affective lability and social functioning in severe mental disorders. | Høegh MC et al. | — | 2022 | → |
| Cognitive Behavioral Therapy Program for Cannabis Use Cessation in First-Episode Psychosis Patients: A 1-Year Randomized Controlled Trial. | González-Ortega I et al. | — | 2022 | → |
| Recovery beyond clinical improvement - Recovery outcomes measured for people with bipolar disorder between 1980 and 2020. | Mezes B et al. | — | 2022 | → |
| Psychological factors in personal and clinical recovery in bipolar disorder. | Mezes B et al. | — | 2021 | → |
| Improved Rehabilitation Outcomes for Persons With and Without Problematic Substance Use After 2 Years With Assertive Community Treatment-A Prospective Study of Patients With Severe Mental Illness in 12 Norwegian ACT Teams. | Clausen H et al. | — | 2020 | → |
| Levels of mental distress over 18 years after entering treatment for substance use disorders: A longitudinal cohort study. | Hjemsæter AJ et al. | — | 2020 | → |
| Adverse impact of marijuana use on clinical outcomes among psychiatry patients with depression and alcohol use disorder. | Bahorik AL et al. | — | 2018 | → |
| Is Capability to Manage Finances Stable Over Time? | Lazar CM et al. | — | 2018 | → |
| Medical and non-medical marijuana use in depression: Longitudinal associations with suicidal ideation, everyday functioning, and psychiatry service utilization. | Bahorik AL et al. | — | 2018 | → |
| Perspectives of cannabis use in the life experience of men with schizophrenia. | Wagstaff C et al. | — | 2018 | → |
| Prevalence and correlates of alcohol use disorders among bipolar patients at Amanuel Mental Specialized Hospital, Addis Ababa (Ethiopia): A cross-sectional institution based study. | Tensae DW et al. | — | 2018 | → |
| Reactivity to addictive drugs in the methylazoxymethanol (MAM) model of schizophrenia in male and female rats. | Ruda-Kucerova J et al. | — | 2017 | → |
| Substance Use Among Homeless Individuals With Schizophrenia and Bipolar Disorder. | Maremmani AG et al. | — | 2017 | → |
| Areas of controversy in neuroprogression in bipolar disorder. | Passos IC et al. | — | 2016 | → |
| Cannabis use in first-treatment bipolar I disorder: relations to clinical characteristics. | Kvitland LR et al. | — | 2016 | → |
| Cognitive behavioral therapy program for cannabis use cessation in first-episode psychosis patients: study protocol for a randomized controlled trial. | González-Ortega I et al. | — | 2016 | → |
| Factors associated with problematic drug use among psychiatric outpatients. | Corradi-Webster CM et al. | — | 2016 | → |
| Heroin use. | Salani DA et al. | — | 2016 | → |
| Prevalence of comorbid bipolar and substance use disorders in clinical settings, 1990-2015: Systematic review and meta-analysis. | Hunt GE et al. | — | 2016 | → |
| Continued cannabis use at one year follow up is associated with elevated mood and lower global functioning in bipolar I disorder. | Kvitland LR et al. | — | 2015 | → |
| Improving the efficiency of drug use disorder screening in psychiatric settings: validation of a single-item screen. | Hearon BA et al. | — | 2015 | → |
| Social functioning trajectories of young first-episode psychosis patients with and without cannabis misuse: a 30-month follow-up study. | González-Blanch C et al. | — | 2015 | → |
| Use and diversion of medical marijuana among adults admitted to inpatient psychiatry. | Nussbaum AM et al. | — | 2015 | → |
| Six-month outcome in bipolar spectrum alcoholics treated with acamprosate after detoxification: a retrospective study. | Icro Maremmani AG et al. | — | 2014 | → |
| The long-term outcomes of heroin dependent-treatment-resistant patients with bipolar 1 comorbidity after admission to enhanced methadone maintenance. | Maremmani AGI et al. | — | 2013 | → |